Your browser doesn't support javascript.
loading
Pharmacological mechanisms of Ma Xing Shi Gan Decoction in treating influenza virus-induced pneumonia: intestinal microbiota and pulmonary glycolysis.
Jiang, Lin; Bai, Chen; Zhu, Jingru; Su, Chen; Wang, Yang; Liu, Hui; Li, Qianqian; Qin, Xueying; Gu, Xiaohong; Liu, Tiegang.
Afiliação
  • Jiang L; College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Bai C; College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Zhu J; Beijing Dingjitang Traditional Chinese Medicine Clinic Co., Ltd., Beijing, China.
  • Su C; College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Wang Y; Traditional Chinese Medicine Department, Beijing Jishuitan Hospital, Captial Medical University, Beijing, China.
  • Liu H; Institute of Traditional Chinese Medicine for Epidemic Diseases, Beijing University of Chinese Medicine, Beijing, China.
  • Li Q; College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Qin X; Department of Respiratory Medicine, The First Clinical College of Beijing University of Chinese Medicine, Beijing, China.
  • Gu X; College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
  • Liu T; College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Front Pharmacol ; 15: 1404021, 2024.
Article em En | MEDLINE | ID: mdl-39161892
ABSTRACT

Background:

Influenza virus is one of the most common pathogens that cause viral pneumonia. During pneumonia, host immune inflammation regulation involves microbiota in the intestine and glycolysis in the lung tissues. In the clinical guidelines for pneumonia treatment in China, Ma Xing Shi Gan Decoction (MXSG) is a commonly prescribed traditional Chinese medicine formulation with significant efficacy, however, it remains unclear whether its specific mechanism of action is related to the regulation of intestinal microbiota structure and lung tissue glycolysis.

Objective:

This study aimed to investigate the mechanism of action of MXSG in an animal model of influenza virus-induced pneumonia. Specifically, we aimed to elucidate how MXSG modulates intestinal microbiota structure and lung tissue glycolysis to exert its therapeutic effects on pneumonia.

Methods:

We established a mouse model of influenza virus-induced pneumoni, and treated with MXSG. We observed changes in inflammatory cytokine levels and conducted 16S rRNA gene sequencing to assess the intestinal microbiota structure and function. Additionally, targeted metabolomics was performed to analyze lung tissue glycolytic metabolites, and Western blot and enzyme-linked immunosorbent assays were performed to assess glycolysis-related enzymes, lipopolysaccharides (LPSs), HIF-1a, and macrophage surface markers. Correlation analysis was conducted between the LPS and omics results to elucidate the relationship between intestinal microbiota and lung tissue glycolysis in pneumonia animals under the intervention of Ma Xing Shi Gan Decoction.

Results:

MXSG reduced the abundance of Gram-negative bacteria in the intestines, such as Proteobacteria and Helicobacter, leading to reduced LPS content in the serum and lungs. This intervention also suppressed HIF-1a activity and lung tissue glycolysis metabolism, decreased the number of M1-type macrophages, and increased the number of M2-type macrophages, effectively alleviating lung damage caused by influenza virus-induced pneumonia.

Conclusion:

MXSG can alleviate glycolysis in lung tissue, suppress M1-type macrophage activation, promote M2-type macrophage activation, and mitigate inflammation in lung tissue. This therapeutic effect appears to be mediated by modulating gut microbiota and reducing endogenous LPS production in the intestines. This study demonstrates the therapeutic effects of MXSG on pneumonia and explores its potential mechanism, thus providing data support for the use of traditional Chinese medicine in the treatment of respiratory infectious diseases.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article